Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Off-Label Wish List: Industry Groups Want US FDA's Guidances To Do More

Mar 09 2017

• By Derrick Gingery

Can telephone with red wire

Related Content

Industry Communications With Payors: US FDA Okays Info On Investigational Drugs

Jan 19 2017

Off-Label Communication: When Does It Align With Approved Labeling?

Jan 18 2017

Off-Label Promotion Decisions Likely Made Case-by-Case, US FDA Official Says

Feb 27 2017

FDA's Document Dump: Guidance Release Skyrockets Ahead Of Trump's Arrival

Jan 22 2017

Off-Label Communication Principles From PhRMA, BIO Aim For Reg Changes

Jul 27 2016

Keep Limits On Off-Label Promotion, Consumers And Patients Say

Nov 11 2016

Off-Label Communications: Industry, FDA Debate Role Of Peer Review

Nov 10 2016

‘Who Is The Arbiter?’ US FDA Asks As It Mulls Loosening Off-Label Reins

Nov 10 2016

Rx Economic Information-Sharing Concept Getting Renewed Push

Jun 30 2016

Related Companies

Sanofi

Additional Topics

United States Advertising, Marketing & Sales FDA Regulation BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window